Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Study to Evaluate the Efficacy of Rosiglitazone (BRL-049653) on Reduction of Microalbuminuria in Subjects with Type 2 Diabetes Mellitus
rosiglitazone
49653/137
NCT00500955
Diabetes Mellitus, Type 2
Phase 3
 
An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013

Powered by ideaPoint, Inc.